This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Conservative management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Medical management is targeted at reducing the symptoms of GERD with drugs that inhibit gastric acid secretion.

  • Proton pump inhibitors (PPIs)
  • Histamine 2 receptor antagonists
  • antacids
  • metoclopramide or domperidone - is not recommended (1)

Drug management of reflux oesophagitis is described in the menu option.

Although evidence supporting the effectiveness of lifestyle modification is weak, these should be recommended according to patients’ circumstances

  • weight loss
  • avoidance of “trigger” foods
  • eat frequent small meals, and not to eat just before bedtime
  • not to lie down after eating a meal and advice to sleep with their head elevated, e.g. by extra pillows.
    • elevating the head of the bed by 6-8 inches (15-20 cm) and avoidance of food three hours before bedtime is especially helpful for patients who are prone to symptoms at night (1)
  • patients should be dissuaded from smoking.

Inflammatory fibrous strictures can be dilated using gum - elastic bougies of progressively increasing size. This is usually done endoscopically

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.